Cargando…
C3 amino-substituted chalcone derivative with selective adenosine rA(1) receptor affinity in the micromolar range
ABSTRACT: To identify novel adenosine receptor (AR) ligands based on the chalcone scaffold, herein the synthesis, characterization and in vitro and in silico evaluation of 33 chalcones (15–36 and 37–41) and structurally related compounds (42–47) are reported. These compounds were characterized by ra...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670844/ https://www.ncbi.nlm.nih.gov/pubmed/33223599 http://dx.doi.org/10.1007/s11696-020-01414-9 |
_version_ | 1783610820916150272 |
---|---|
author | Janse van Rensburg, Helena D. Legoabe, Lesetja J. Terre’Blanche, Gisella |
author_facet | Janse van Rensburg, Helena D. Legoabe, Lesetja J. Terre’Blanche, Gisella |
author_sort | Janse van Rensburg, Helena D. |
collection | PubMed |
description | ABSTRACT: To identify novel adenosine receptor (AR) ligands based on the chalcone scaffold, herein the synthesis, characterization and in vitro and in silico evaluation of 33 chalcones (15–36 and 37–41) and structurally related compounds (42–47) are reported. These compounds were characterized by radioligand binding and GTP shift assays to determine the degree and type of binding affinity, respectively, against rat (r) A(1) and A(2A) ARs. The chalcone derivatives 24, 29, 37 and 38 possessed selective A(1) affinity below 10 µM, and thus, are the most active compounds of the present series; compound 38 was the most potent selective A(1) AR antagonist (K(i) (r) = 1.6 µM). The structure–affinity relationships (SAR) revealed that the NH(2)-group at position C3 of ring A of the chalcone scaffold played a key role in affinity, and also, the Br-atom at position C3′ on benzylidene ring B. Upon in vitro and in silico evaluation, the novel C3 amino-substituted chalcone derivative 38—that contains an α,ß-unsaturated carbonyl system and easily allows structural modification—may possibly be a synthon in future drug discovery. GRAPHIC ABSTRACT: C3 amino-substituted chalcone derivative (38) with C3′ Br substitution on benzylidene ring B possesses selective adenosine rA(1) receptor affinity in micromolar range. [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11696-020-01414-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7670844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-76708442020-11-18 C3 amino-substituted chalcone derivative with selective adenosine rA(1) receptor affinity in the micromolar range Janse van Rensburg, Helena D. Legoabe, Lesetja J. Terre’Blanche, Gisella Chem Zvesti Original Paper ABSTRACT: To identify novel adenosine receptor (AR) ligands based on the chalcone scaffold, herein the synthesis, characterization and in vitro and in silico evaluation of 33 chalcones (15–36 and 37–41) and structurally related compounds (42–47) are reported. These compounds were characterized by radioligand binding and GTP shift assays to determine the degree and type of binding affinity, respectively, against rat (r) A(1) and A(2A) ARs. The chalcone derivatives 24, 29, 37 and 38 possessed selective A(1) affinity below 10 µM, and thus, are the most active compounds of the present series; compound 38 was the most potent selective A(1) AR antagonist (K(i) (r) = 1.6 µM). The structure–affinity relationships (SAR) revealed that the NH(2)-group at position C3 of ring A of the chalcone scaffold played a key role in affinity, and also, the Br-atom at position C3′ on benzylidene ring B. Upon in vitro and in silico evaluation, the novel C3 amino-substituted chalcone derivative 38—that contains an α,ß-unsaturated carbonyl system and easily allows structural modification—may possibly be a synthon in future drug discovery. GRAPHIC ABSTRACT: C3 amino-substituted chalcone derivative (38) with C3′ Br substitution on benzylidene ring B possesses selective adenosine rA(1) receptor affinity in micromolar range. [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11696-020-01414-9) contains supplementary material, which is available to authorized users. Springer International Publishing 2020-11-17 2021 /pmc/articles/PMC7670844/ /pubmed/33223599 http://dx.doi.org/10.1007/s11696-020-01414-9 Text en © Institute of Chemistry, Slovak Academy of Sciences 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Paper Janse van Rensburg, Helena D. Legoabe, Lesetja J. Terre’Blanche, Gisella C3 amino-substituted chalcone derivative with selective adenosine rA(1) receptor affinity in the micromolar range |
title | C3 amino-substituted chalcone derivative with selective adenosine rA(1) receptor affinity in the micromolar range |
title_full | C3 amino-substituted chalcone derivative with selective adenosine rA(1) receptor affinity in the micromolar range |
title_fullStr | C3 amino-substituted chalcone derivative with selective adenosine rA(1) receptor affinity in the micromolar range |
title_full_unstemmed | C3 amino-substituted chalcone derivative with selective adenosine rA(1) receptor affinity in the micromolar range |
title_short | C3 amino-substituted chalcone derivative with selective adenosine rA(1) receptor affinity in the micromolar range |
title_sort | c3 amino-substituted chalcone derivative with selective adenosine ra(1) receptor affinity in the micromolar range |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670844/ https://www.ncbi.nlm.nih.gov/pubmed/33223599 http://dx.doi.org/10.1007/s11696-020-01414-9 |
work_keys_str_mv | AT jansevanrensburghelenad c3aminosubstitutedchalconederivativewithselectiveadenosinera1receptoraffinityinthemicromolarrange AT legoabelesetjaj c3aminosubstitutedchalconederivativewithselectiveadenosinera1receptoraffinityinthemicromolarrange AT terreblanchegisella c3aminosubstitutedchalconederivativewithselectiveadenosinera1receptoraffinityinthemicromolarrange |